"The infrared analysis of protein structures in peripheral blood mononuclear leukocytes allows one to differentiate, with sensitivity and specificity around 85% between healthy controls and Alzheimer patients in the early stages of the disease, with advantage for effective treatment."

Research conducted by Dr. Pedro Carmona of IEM-CSIC